LGHT vs. SBIO ETF Comparison

Comparison of Langar Global HealthTech ETF (LGHT) to ALPS Medical Breakthroughs ETF (SBIO)
LGHT

Langar Global HealthTech ETF

LGHT Description

LGHT targets the global healthcare technology industry. The fund actively invests in HealthTech companies, which the adviser defines as firms that develop technology designed to create healthcare efficiency by addressing key pain points for patients, providers, payors, and hospitals, including those companies that derive a majority of their revenue from HealthTech products and services. The portfolio construction starts by identifying companies that fit into the advisers HealthTech definition. The remaining companies are screened using a proprietary metric that assesses each firms financial health, involvement in relevant controversies, as well as the strength of its team and culture. Each company is then assigned an industry risk score through an algorithm that defines quantitative and qualitative risk categories and weights them accordingly. Finally, each company is reviewed by an investment committee. However, the portfolio manager still has full discretion over the final selection.

Grade (RS Rating)

Last Trade

$10.25

Average Daily Volume

820

Number of Holdings *

31

* may have additional holdings in another (foreign) market
SBIO

ALPS Medical Breakthroughs ETF

SBIO Description The investment seeks investment results that correspond (before fees and expenses) generally to the performance of its underlying index, the Poliwogg Medical Breakthroughs IndexSM. The fund employs a "passive management" - or indexing - investment approach designed to track the performance of the underlying index. It will normally invest at least 80% of its net assets in securities that comprise the underlying index. The underlying index is comprised of small- and mid-cap stocks of biotechnology and pharmaceutical companies that have one or more drugs in either Phase II or Phase III U.S. Food and Drug Administration clinical trials. It is non-diversified.

Grade (RS Rating)

Last Trade

$36.89

Average Daily Volume

8,125

Number of Holdings *

83

* may have additional holdings in another (foreign) market
Performance
Period LGHT SBIO
30 Days -4.07% -7.77%
60 Days -3.03% -4.88%
90 Days -1.92% -1.09%
12 Months 44.40%
1 Overlapping Holdings
Symbol Grade Weight in LGHT Weight in SBIO Overlap
ALKS C 0.66% 3.15% 0.66%
LGHT Overweight 30 Positions Relative to SBIO
Symbol Grade Weight
ISRG A 15.39%
GEHC D 8.56%
RMD C 6.71%
IQV F 6.34%
DXCM C 5.51%
PODD B 5.26%
VEEV C 5.15%
PHG F 4.87%
ZBH C 3.57%
BNTX C 3.53%
ALGN D 2.85%
MASI B 2.46%
DOCS C 2.06%
MRNA F 1.72%
PRCT B 1.27%
TNDM F 0.54%
IRTC C 0.44%
PRVA C 0.44%
OMCL C 0.42%
LFST C 0.31%
TDOC D 0.28%
PGNY F 0.25%
EVH F 0.22%
SDGR C 0.21%
GDRX F 0.2%
ALHC C 0.2%
PHR F 0.17%
ACCD F 0.07%
MODV D 0.03%
TBRG A 0.03%
LGHT Underweight 82 Positions Relative to SBIO
Symbol Grade Weight
CORT C -3.66%
KRYS C -3.39%
RNA C -3.29%
ACLX C -3.19%
CRNX C -2.95%
IMVT F -2.66%
DNLI C -2.36%
MRUS F -2.21%
AGIO C -2.05%
PTCT C -2.02%
XENE D -2.01%
VRNA B -1.98%
FOLD F -1.95%
EWTX C -1.92%
ACAD C -1.89%
VERA C -1.82%
ZLAB C -1.79%
VCEL A -1.73%
PTGX D -1.61%
CGON F -1.57%
IDYA F -1.53%
GERN F -1.48%
MIRM C -1.47%
KROS D -1.4%
LBPH A -1.4%
AKRO C -1.32%
MNKD B -1.26%
IRON C -1.21%
GLPG F -1.19%
TARS C -1.16%
IMCR C -1.07%
CLDX F -1.06%
ARVN F -1.06%
BCRX D -0.99%
XNCR B -0.98%
RCUS F -0.95%
NTLA F -0.94%
SNDX F -0.93%
SPRY C -0.88%
VRDN D -0.84%
KURA F -0.83%
DAWN D -0.82%
AUPH C -0.78%
PHVS D -0.76%
APLT C -0.72%
COGT D -0.69%
ETNB D -0.57%
LQDA F -0.54%
PLRX D -0.53%
PRTA F -0.52%
ERAS C -0.51%
REPL C -0.5%
IRWD F -0.44%
AVXL C -0.42%
ANNX F -0.4%
MLYS D -0.39%
ALT C -0.37%
OLMA F -0.37%
ANAB F -0.36%
FLGT F -0.35%
ALLO F -0.35%
CELC F -0.34%
YMAB F -0.34%
URGN F -0.34%
SVRA F -0.34%
FULC F -0.33%
TBPH B -0.32%
FDMT F -0.31%
GHRS C -0.31%
ARCT F -0.31%
AURA C -0.3%
ALEC F -0.28%
CMPS F -0.23%
ACIU D -0.22%
VNDA C -0.2%
ITOS F -0.19%
STRO D -0.17%
ALDX C -0.17%
ZNTL D -0.17%
ENTA F -0.14%
INZY F -0.12%
HLVX F -0.06%
Compare ETFs